Table 2.
NC (n = 10) | DM (n = 10) | TL (n = 10) | TM (n = 10) | TH (n = 10) | |
---|---|---|---|---|---|
E-cadherin | 3.21 ± 0.58 | 0.27 ± 0.16a | 1.01 ± 0.29a,b | 2.46 ± 0.37a,b,c | 2.62 ± 0.41a,b,c |
α-SMA | 0.24 ± 0.15 | 3.19 ± 0.29a | 2.63 ± 0.21a,b | 2.14 ± 0.18a,b,c | 1.57 ± 0.20a,b,c,d |
TLR4 | 0.19 ± 0.12 | 2.92 ± 0.17a | 2.24 ± 0.18a,b | 1.73 ± 0.15a,b,c | 1.29 ± 0.14a,b,c,d |
NF-κB | 0.35 ± 0.19 | 4.12 ± 0.21a | 3.81 ± 0.22a,b | 3.09 ± 0.17a,b,c | 1.94 ± 0.19a,b,c,d |
IL-1β | 0.31 ± 0.11 | 3.48 ± 0.24a | 2.89 ± 0.15a,b | 2.19 ± 0.15a,b,c | 1.96 ± 0.17a,b,c |
MCP-1 | 0.36 ± 0.09 | 3.07 ± 0.26a | 2.31 ± 0.12a,b | 1.54 ± 0.18a,b,c | 1.15 ± 0.15a,b,c,d |
NC: normal control; DM: diabetic rats without drug treatment; TL: low-dose TGT (1 mg/kg/day); TM: medium-dose TGT (3 mg/kg/day); TH: high-dose TGT (6 mg/kg/day). a p < 0.05 versus NC group, b p < 0.05 versus DM group, c p < 0.05 versus TL group, and d p < 0.05 versus TM group.